Thrombocytopenia and outcome in invasive cardiology.
Lewis
Bruce
B
Loyola University Medical Center, Maywood, Illinois, USA.
D000800:Angioplasty, Balloon / Q000009:adverse effects*; D000925:Anticoagulants / Q000009:adverse effects; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000150:complications / Q000628:therapy; D005060:Europe / Q000453:epidemiology; D006493:Heparin / Q000009:adverse effects; D006801:Humans; D015994:Incidence; D019060:Minimally Invasive Surgical Procedures; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000037:antagonists & inhibitors / Q000627:therapeutic use; D011183:Postoperative Complications / Q000139:chemically induced / Q000188:drug therapy / Q000453:epidemiology; D011697:Purpura, Thrombotic Thrombocytopenic / Q000139:chemically induced / Q000188:drug therapy; D011725:Pyridines / Q000627:therapeutic use; D012307:Risk Factors; D012720:Severity of Illness Index; D013577:Syndrome; D013921:Thrombocytopenia / Q000139:chemically induced* / Q000188:drug therapy / Q000453:epidemiology; D017211:Treatment Failure; D014481:United States / Q000453:epidemiology
D000925:Anticoagulants; D019039:Platelet Glycoprotein GPIIb-IIIa Complex; D011725:Pyridines; C446540:thienopyridine; D006493:Heparin